Previous 10 | Next 10 |
The Company also highlights the study design for its pipeline program to predict response to systemic therapeutics in patients diagnosed with moderate to severe inflammatory dermatologic conditions Castle Biosciences, Inc. (Nasdaq: CSTL), applying innovative diagnostics to t...
Fuels mid- and long-term growth with TissueCypher ® platform enabling GI franchise Acquisition will expand Castle’s estimated U.S. TAM by approximately $1 billion Castle executive management to host conference call and webcast today at 7:30 a.m. ET ...
Maetzold’s presentation will take place during the AZAdvances Life Science Innovation Showcase on October 6 Castle Biosciences, Inc. (Nasdaq: CSTL), a dermatologic diagnostics company providing personalized genomic information to inform treatment decisions, today anno...
The following slide deck was published by Castle Biosciences, Inc. in conjunction with this event. For further details see: Castle Biosciences Inc <<CSTL>> presents at the Global Healthcare Virtual Conference 2021 - slideshow
Castle Biosciences, Inc. (Nasdaq: CSTL), a dermatologic diagnostics company providing personalized genomic information to improve treatment decisions, today announced that it has received approval from the New York State Department of Health for its proprietary DecisionDx® DiffDx...
The following slide deck was published by Castle Biosciences, Inc. in conjunction with this event. For further details see: Castle Biosciences (CSTL) 2021 Wells Fargo Virtual Healthcare Conference- Slideshow
Castle Biosciences, Inc. (Nasdaq: CSTL), a dermatologic diagnostics company providing personalized genomic information to inform treatment decisions, today announced that it has been included in The Healthcare Technology Report’s Top 100 Healthcare Technology Companies of 202...
Expands DecisionDx®-Melanoma Coverage to Veterans Health Administration and Military Health System Medical Centers Castle Biosciences, Inc. (Nasdaq: CSTL), a dermatologic diagnostics company providing personalized genomic information to inform treatment decisions, today...
Castle Biosciences, Inc. (Nasdaq: CSTL), a dermatologic diagnostics company providing personalized genomic information to inform treatment decisions, today announced recent presentations on two of its skin cancer gene expression profile tests at the 2021 American Academy of Dermatology ...
Castle Biosciences, Inc. (CSTL) Q2 2021 Earnings Conference Call August 9, 2021 4:30 PM ET Company Participants Camilla Zuckero - Executive Director, Investor Relations & Corporate Communications Derek Maetzold - Founder, President & Chief Executive Officer Frank Stokes - Chief Financ...
News, Short Squeeze, Breakout and More Instantly...
Castle Biosciences Inc. Company Name:
CSTL Stock Symbol:
NASDAQ Market:
Castle Biosciences Inc. Website:
Campaign will focus on empowering patients impacted by melanoma Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, has joined forces with television personality, wellness coach and founder of ALL IN by Teddi, host of the...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the second quarter and six months ended June 30, 2024, after the close of market on Monday, Aug. 5, 2024. Compan...
Castle earns recognition as an Arizona Top Workplace, a national Healthcare Industry Top Workplace and receives five Top Workplaces Culture Excellence Awards Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today annou...